ing to Mcl-1 expression is facilitated by α-toxin released by intracellular bacteria which permeabilize phagosomes, ensuring pathogen access to the cytoplasmatic compartment. Given that the intracellular survival of S. aureus depends on α-toxin, we propose a novel role for this agent in the protection of the intracellular niche, and further dissemination of staphylococci by infected macrophages.
reus escape from endocytic vesicles into the cytosol [6] . In macrophages, α-toxin-dependent evasion of phagosomes promotes resistance to killing by the phagocyte, as determined by TEM imaging of phagosome membrane damage [7] . At the same time, an increasing body of evidence indicates that α-toxin sensing by the host is important for triggering an immune response [8] , and contributes to host defense against systemic infection by staphylococci [9, 10] . Indeed, S. aureus sensing by innate immunity is mediated mainly via Toll-like receptors (TLRs), and the group of nucleotide-binding oligomerization domain (NOD)-like receptors [11] that detect bacterial antigens in the cytoplasm. Recently, we showed that live intracellular staphylococci induce cytoprotection in human macrophages to promote survival of infected cells without bacterial eradication, allowing the pathogen to silently persist and remain invisible to the immune system [7, 12] . Moreover, we proposed that the pathogen induces a prosurvival signaling pathway through the induction of expression of antiapoptotic factors, including myeloid cell leukemia-1 (Mcl-1), an antiapoptotic protein of the Bcl-2 family [13] . In this context, the physiological significance of α-toxin interaction with detection systems associated with innate immunity for the survival of S. aureus in infected macrophages has not yet been elucidated.
The results of this study demonstrate a novel mechanism of dependence for Mcl-1 expression on α-toxin production by bacteria, since Hla producers, in comparison to strains deficient in this factor, induced the highest levels of Mcl-1 and cytoprotection. Furthermore, we established that α-toxin-mediated induction of Mcl-1 expression required the IL-6 and NFκB transcription pathway. Mcl-1 expression in infected macrophages was largely independent of extracellular TLR2 signaling, so we propose that the observed induction of expression is the result of intracellular receptor(s) activation.
Materials and Methods

Reagents
Gentamycin, L -glutamine, DEVD-AFC peptide substrate, SYBR Green JumpStart Taq Ready Mix, erythromycin, tetracycline, RNase A, proteinase K, bovine serum albumin, tryptic soy agar, tryptic soy broth, staurosporine, staphylococcal α-toxin protein and FITC were from Sigma (Saint Louis, Mo., USA). Fetal calf serum, RPMI 1640, DMEM, phosphate-buffered saline (PBS; without Ca 2+ and Mg 2+ ) and lymphocyte separation medium were obtained from PAA (Pasching, Austria). The Pro-Ject protein transfection kit was from Pierce (Rockford, Ill., USA). Rabbit polyclonal anti-human Mcl-1 antibodies were purchased from Santa Cruz Biotechnology (Dallas, Tex., USA) and mouse monoclonal anti-β-actin from Sigma. S. aureus-derived peptidoglycan (PGN) was from Invitrogen (Carlsbad, Calif., USA). Secondary horseradish peroxidase (HRP)-conjugated antibodies, donkey anti-rabbit IgG and sheep anti-mouse IgG were obtained from Amersham Biosciences (Freiburg, Germany) and Sigma, respectively. The neutralizing antibodies against human IL-6 receptor (IL-6R) were from R&D Systems. TLR2 [TL2.1] and TLR4 [HTA125] were from Abcam (Cambridge, Mass., USA).
Cell Culture
Human monocyte-derived macrophages (hMDMs) were differentiated from peripheral blood mononuclear cells as described previously [12] . Blood was obtained from the Red Cross, Krakow, Poland. The Red Cross deidentifies blood materials, as is appropriate for human subject confidentiality assurances. This study therefore did not require consent from any patients or approval by any IRB. Briefly, PBMCs were isolated from human blood using a lymphocyte separation medium density gradient, yielding a fraction highly enriched in monocytes (90% CD14-positive), as described previously. Cells were plated at 3 × 10 6 /well in 24-well plates (Sarstedt, Numbrecht, Germany) in RPMI 1640 supplemented with 2 m M L -glutamine, 50 μg/ml gentamycin, and 10% autological human serum. After 24 h, nonadherent PBMCs were removed by washing with complete medium, and adherent cells were cultured in this medium for 7 days, with media changed every 2 days. The murine macrophage cell line RAW 264.7 obtained from the American Type Culture Collection was maintained in DMEM supplemented with 5% fetal bovine serum.
Bacterial Strains, Storage and Growth Conditions
Laboratory S. aureus strains (from lab stocks, as well as kindly provided by Dr. T.J. Foster, Trinity College, Dublin, Ireland) used in this study are listed in table 1 . The strains were stored in tryptic soy broth medium containing glycerol (50% v/v) at -80 ° C. Cultures were inoculated from stocks into 10 ml of media. S. aureus strains were grown to stationary phase at 37 ° C overnight, with shaking (180 rpm). If required, media were supplemented with antibiotics at the following concentration: erythromycin at 5 μg/ ml or tetracycline at 2 μg/ml. Bacterial cells were collected by cen- hla::Erm trifugation (5,000 g for 8 min), washed with PBS and resuspended in PBS to the desired optical density (OD) 600 . The numbers of vital bacteria in samples used for phagocytosis assay were routinely verified by plating dilutions on agar plates and counting colonies to determine CFUs/ml. Heat treatment (80 ° C for 1 h) was used to kill bacteria.
Infection of Macrophages
To infect macrophages, phagocytosis with S. aureus was carried out for 2 h at 37 ° C at a multiplicity of infection (MOI) of 1: 50 ( hMDMs) or 1: 5 (RAW 264.7). This resulted in >85% of macrophages engulfing at least one bacterium, as verified by plating cell lysates and counting colonies to determine CFUs. Infected cells were rinsed 4 times with ice-cold PBS, and any remaining nonphagocytosed bacteria were killed by culturing in medium containing gentamycin (50 μg/ml). The ability of intracellular S. aureus to form colonies was determined 2, 6, 24 and 48 h after the infection of macrophages by plating cell homogenates on agar and counting colonies (in CFUs). For toxin supplementation experiments, α-toxin or bacterial culture medium (0.3%) was added simultaneously with S. aureus . Blocking experiments for IL-6R, TLR2 and TLR4 were performed with anti-IL-6R, anti-TLR2 and anti-TLR4 monoclonal antibodies (mAbs). Briefly, noninfected cells were incubated with 1-5 μg/ml of each mAb for 30 min at 37 ° C, before the macrophages were infected with bacteria and the effects on cells were evaluated.
Analysis of Caspase-3 Activity
The activity of caspase-3, a main executioner caspase involved in the apoptotic process, was determined by release of AFC (7-amino-4-trifluoromethyl-coumarin) from a DEVD-AFC peptide substrate. Both control cells and those exposed to S. aureus , with or without apoptotic stimuli, were collected by centrifugation (200 g for 5 min at 4 ° C), washed with ice-cold PBS and resuspended in 100 μl of lysis buffer (50 m M Tris, pH 7.5, 150 m M NaCl, 1% NP-40, 0.5% deoxycholic acid, 0.1% SDS). Samples were then incubated on ice for 20 min and subjected to centrifugation (16,000 g for 10 min). The protein content of supernatants was measured using the BCA method. Caspase activity was determined by transferring aliquots of supernatant into buffer (40 m M Pipes, 20% sucrose, 200 m M NaCl, 0.2% CHAPS, 2 m M EDTA) containing DEVD-AFC and recording increased fluorescence (λ ex = 350 nm, λ em = 460 nm) for released AFC using a Spectra Max Gemini EM (Molecular Devices). Additionally, processing of 32 kDa procaspase-3 to its active form (20-kDa and 11 kDa chains) was determined in cells by Western blot.
Protein Isolation and Immunoblotting
Whole-cell extracts from control and S. aureus -exposed macrophages were prepared from cells detached with a rubber policeman, and harvested from culture medium into microfuge tubes. Cells were washed twice with PBS (250 g for 5 min), resuspended in 100 μl of RIPA-lysis buffer (0.25% Na-deoxycholate, 0.5% Nonidet P-40, 0.05% SDS, protease inhibitor cocktail, 2.5 m M EDTA in PBS) and stored at -20 ° C. Equal amounts of protein (40 μg/ well) were separated by SDS-PAGE (8, 12 or 16% gels depending on the molecular mass of proteins of interest) and electrotransferred onto nitrocellulose membranes (BioRad) in buffer composed of 25 m M Tris, 0.2 M glycine, 20% methanol (30 V, overnight). Membranes were stained with Ponceau S to analyze the efficiency of transfer and loading precision (same amount of protein loaded per well). Nonspecific binding sites were blocked with 3% bovine serum albumin in TTBS buffer (20 m M Tris, 0.5 M NaCl, pH 7.5 with 0.05% Tween 20) for 1 h, followed by incubation for 1-2 h with the relevant primary antibody: 100-fold diluted anti-Mcl-1 or 3,000-fold diluted anti-β-actin. Membranes were washed extensively in TTBS buffer and incubated with secondary HRP-conjugated antibodies, 10,000-fold diluted donkey anti-rabbit IgG or 20,000-fold diluted sheep anti-mouse IgG, for 1 h in TTBS buffer containing 1% bovine serum albumin. Membranes were washed (4 × 15 min) in TTBS buffer and blots were developed using ECL detection (Western Blotting Detection Reagents, Amersham Biosciences).
To estimate the level of α-toxin secretion by S. aureus strains, 20 μl of bacterial culture media were subjected to SDS-PAGE (15% gel) as described above. As a positive control, rHla was used at a concentration of 0.25 μg. To detect α-toxin, a 10,000-fold dilution of anti-α-hemolysin antibody (Abcam) was used, followed by incubation with 10,000-fold diluted donkey anti-rabbit IgG HRPconjugated secondary antibodies.
Densitometric Analyses
Densitometric analyses of Western blots were performed using Kodak digital software. Results are presented as mean values of arbitrary densitometric units corrected for background intensity, or as increases over levels in nonstimulated cells.
Quantitative PCR
Total cellular RNA was extracted from cultured hMDMs using an RNeasy mini kit (Qiagen), according to the manufacturer's instructions. RNA samples were DNase treated and cDNA was prepared by reverse transcription using RevertAid TM First Strand cDNA synthesis kit (Fermentas, Germany). RNA (500 ng) from each sample was used for cDNA synthesis reactions with oligo (dT) primers according to the manufacturer's instructions. Quantitative PCR (qRT-PCR) reactions were performed using SYBR Green, in a reaction volume of 20 μl, containing 1 μl of cDNA sample, 0.5 μ M of each primer and 1 × SYBR Green JumpStart Taq Ready Mix. qRT-PCR forward and reverse primers for IL-6, MCL-1 , and NOD2 genes, and for the housekeeping EF-2 gene (used for normalization), are listed in table 2 . After 5 min of 
initial denaturation at 95 ° C, reactions were carried out for 40 cycles in the following conditions: denaturation at 95 ° C for 20 s, annealing at 56-62 ° C (as shown in table 2 ) for 60 s, extension at 72 ° C for 60 s; followed by a final elongation step at 72 ° C for 10 min. All reactions were performed in duplicate. Means for threshold cycle (Ct) values were calculated and analyzed using the 'delta-delta Ct' quantification method [14] . For the evaluation of qRT-PCR reaction quality, samples were routinely resolved on nondenaturing 1.5% agarose gels and visualized by staining with ethidium bromide.
Intracytoplasmic Delivery of Staphylococcal α-Toxin Protein
Purified staphylococcal α-toxin protein (30 ng/ml) was delivered into hMDMs using the cationic lipid mixture Pro-Ject protein transfection kit. Briefly, Pro-Ject reagents were solubilized in chloroform and aliquoted into 10 μl amounts. After chloroform evaporation, aliquots were stored at -20 ° C until use. α-Toxin was diluted in PBS and added to the dried Pro-Ject aliquot. After 5 min of incubation at room temperature (RT; allowing α-toxin/ Pro-Ject reagent complex formation), 1 ml of RPMI 1640 medium was mixed with the sample and the whole volume was added to hMDMs previously rinsed with serum-free medium. After 3 h of incubation, cells were rinsed twice with ice-cold PBS and conditioned in serum-containing medium for an additional 5 h, until RNA extraction was performed. Efficacy of protein delivery was evaluated with the Pro-Ject FITC-labeled antibody against β-galactosidase (used as a positive control) and fluorescence microscopy analysis.
Expression of α-Toxin mRNA by S. aureus inside Macrophages
RNA was isolated from S. aureus-infected hMDMs using the Total RNA mini kit (A&A Biotechnology). Bacterial cells were mechanically disrupted with FastPrep-FP120 Instrument (Savant Bio101). Before cDNA synthesis, RNA was digested with RQ1 RNase (Promega) and repurified with the TRI Reagent (Ambion, Life Technologies). Next RNA (0.85 μg) was reverse-transcribed using the cDNA High Capacity cDNA reverse transcription kit (Applied Biosystems). Transcript levels were analyzed with target specific primers, for hla : hlaFor-ATTTGCACCAATAAGGC CGC and hlaRev-TGGTTTAGCCTGGCCTTCAG and for 16S rRNA: 16SFor-GCTGCCCTTTGTATTGTC and 16SRev-AGA TGTTG GGTTAAGTCCC. Real-time PCR was performed using a CFX96 Touch machine. Reaction mixtures consisted of 7.5 μl of SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich), 1 μl of 300 n M of primers mix, 5 μl of 10× diluted cDNA and 1.5 μl water. PCR parameters were: an initial denaturation step at 94 ° C for 3 min, followed by 40 cycles of 10 s at 94 ° C, of 20 s at 55 ° C and of 45 s at 72 ° C. All samples were analyzed in triplicate. Relative transcript levels were calculated using the modified ΔΔCt method [14] . PCR reactions to confirm a lack of contamination with genomic DNA were performed on RNA samples not subject to reverse transcription, using an identical protocol as for qRT-PCR.
Cytokine Assay
Cell culture (200 μl) supernatant were collected and stored at -80 ° C until analyzed. The level of IL-6 was determined using a commercially available ELISA kit according to the manufacturer's instructions (R&D Systems).
Evaluation of NFκB Activity
NFκB activity was measured in nuclear protein extracts using the TransAM NFκB p65 protein assay (Active Motif, Carlsbad, Calif., USA), an ELISA-based method designed to specifically detect and quantify NFκB p65 subunit activation with high sensitivity and reproducibility. In brief, DNA binding of p65-containing NFκB dimers was examined using a 96-well plate with an immobilized oligonucleotide containing an NFκB consensus-binding site (5-GGGACTTTCC-3). Five micrograms of total nuclear protein was incubated in wells for 1 h at RT. These were then washed 3 times, and 100 μl of anti-p65 subunit mAb (1: 1,000 dilution) was added to each well, before incubation at RT for 1 h. Wells were again washed 3 times, and 100 μl of HRP-conjugated secondary antibody anti-murine IgG (1: 1,000 dilution) was added to each well. After 1 h at RT, plates were washed 4 times, and 100 μl of developing solution was added to each well for 5 min. The absorbance was determined on a spectrophotometer Spectra Max Gemini EM (Molecular Devices) at 450 nm with a reference wavelength of 655 nm. TNF-α-stimulated Jurkat nuclear extracts were used as positive controls, and a 200-fold excess of wild-type (WT) and mutated NFκB consensus oligonucleotides (all provided with the kit) were used to monitor the specificity of the assays.
Hemolysin Assay
Bacterial samples taken at the indicated time points after inoculation were standardized to the same OD (OD 600 = 1.5) and centrifuged (5,500 g at 4 ° C for 2 min) to remove bacteria. Supernatant (100 μl) was diluted to 1 ml in hemolysin buffer (0.145 M NaCl, 20 m M CaCl 2 ) prior to the addition of 25 μl of defibrinated rabbit blood. After incubation for 15 min at 37 ° C, samples were centrifuged (5,500 g at RT for 1 min) and the OD of the supernatant was measured at 543 nm. Percent hemolysis was calculated using the formula: % hemolysis = (absorbance of sample -absorbance of blank) × 100/(absorbance of positive control), where the blank is hemolysin buffer and the positive control is defibrinated rabbit blood with all erythrocytes lysed by 2% Triton X-100 in hemolysin buffer.
Statistics
Results were analyzed for statistical significance using a nonparametric Student's t test or one-way ANOVA test with the Bonferroni post hoc test. Differences were considered significant when p < 0.05.
Results
Mcl-1 Induction by S. aureus Is Dependent on α-Toxin Expression
Recently, we showed that S. aureus can protect infected macrophages from apoptosis via the upregulation of crucial antiapoptotic genes, in particular, MCL-1 (myeloid cell leukemia-1) . To investigate whether the induction of Mcl-1 expression in macrophages was dependent on S. aureus α-toxin (Hla), macrophages were infected with 3 different S. aureus strains: Newman, SH1000 and USA300, along with their corresponding α-toxin-deficient mutants -Δ hla . The efficiency of internalization and intracellular survival for corresponding pairs (Δ hla and parental WT strain) was tested 2 h after the infection of macrophages by plating cell lysates and performing CFU counts. In each case, there appeared to be little or no variation between WT and mutant strains (online suppl. fig. S1A -C; for all online suppl. material, see www.karger. com/doi/10.1159/000368048). In contrast to WT strains, however, all α-toxin-deficient mutants exhibited a significantly reduced capacity to induce MCL-1 mRNA expression ( fig. 1 a) . Importantly, MCL-1 expression was determined 6 h after infection, with no statistical difference in bacterial survival within macrophages observed ( fig. 1 b) . Collectively, these results indicate that α-toxin plays a key role in the upregulation of MCL-1 expression in infected macrophages, in a manner independent of the ability of the toxins to abrogate killing of phagocytized S. aureus [7] . Interestingly, we noted that the MCL-1 expression induced by different S. aureus strains does not correlate with the α-toxin levels secreted by them ( fig. 1 a, c) . The most potent inducer of MCL-1 expression in hMDMs is the Newman strain ( fig. 1 a) , which secretes lower amount of toxin than USA300 ( fig. 1 c) . Such observations indicate that α-toxin is necessary, but not sufficient, for the induction of MCL-1 expression by S. aureus in infected macrophages. Since Newman appears to be the most potent inducer of MCL-1 , and with the difference in Mcl-1 induction compared to its Δ hla mutant being significant, we routinely performed all further experiments in this strain. To verify whether the difference in induction of MCL-1 expression changes during infection, we assessed MCL-1 levels at different time points after macrophage challenge with bacteria. Our data revealed sustained expression of MCL-1 following infection with the WT S. aureus Newman strain in comparison to its α-toxin-deficient mutant (Δhla) ( fig. 2 a) . Further investigation revealed that similar changes also occurred at the protein level ( fig. 2 b) , since both the Δ hla mutant and heat-inactivated (HI) WT exhibited largely reduced hemolytic activity (online suppl. fig. S2 ), and led to markedly lower levels of Mcl-1 expression than the parental strain. These results argue that α-toxin has an important role in the induction of Mcl-1 expression in infected macrophages.
Mcl-1 Induction Requires the Presence of Both α-Toxin and S. aureus
α-Toxin, as a secretory protein, can impact the exterior of macrophages, acting at the plasma membrane or within infected cells when produced by internalized bacteria. To distinguish these two modes of action, adher- ent macrophages were treated with purified α-toxin or else it was injected directly into the cells using an intracytoplasmic delivery system. Surprisingly, neither the extracellular nor intracellular application of α-toxin alone had any effect on MCL-1 expression, as determined by q-PCR and immunoblot analysis ( fig. 3 a, upper and lower panels, respectively). In contrast to macrophages infected with live, toxin-producing S. aureus , which express a large amount of Mcl-1, the Mcl-1 levels in toxin-treated macrophages remained at the same low level as mock-infected cells ( fig. 3 a) . These results indicated that α-toxin alone does not affect Mcl-1 expression per se, but is perhaps required to enhance Mcl-1 expression induced by S. aureus . To investigate this possibility, macrophages infected with the S. aureus Δ hla strain were treated with purified α-toxin, and the effects on MCL-1 expression were assessed. As shown in figure  3 b, the extracellular application of purified recombinant α-toxin resulted in its internalization by macrophages ( fig. 3 c) and potent upregulation of MCL-1 expression in macrophages infected with Newman Δ hla , to the levels observed upon infection with the WT strain. The role of α-toxin in MCL-1 induction observed in hMDMs infected with the WT strain is further supported by sustained hla mRNA levels by intracellular S. aureus cells ( fig. 3 d) . These results confirm that intracellularly distributed α-toxin in the context of live bacteria is a prerequisite for full-scale induction of Mcl-1 expression in S. aureus -infected macrophages.
α-Toxin-Dependent Mcl-1 Induction Is Regulated by IL-6
We have recently shown that IL-6 plays a role in S. aureus-mediated Mcl-1 expression in hMDMs [13] . To determine the role of α-toxin in this process, macrophages were stimulated with Newman or its Δ hla mutant strain. Our results revealed that the mutant exhibited a significantly reduced capacity to induce IL-6 secretion by hMDMs ( fig. 4 a) . Moreover, we observed that complementation of the mutant with purified α-toxin, or bacterial growth medium containing active toxin (as determined by hemolysis assay; see online suppl. fig. S2 ), resulted in significantly higher levels of IL-6 secretion ( fig. 4 a) , in a manner similar to the enhancement of MCL-1 expression illustrated in figure 3 b. Thus, α-toxin contributes to enhanced IL-6 expression as well as the upregulation of MCL-1 . The importance of IL-6 in the upregulation of Mcl-1 mediated by α-toxin-exposed hMDMs was verified by treatment of hMDMs with the IL-6R neutralizing antibodies. As shown in figure 4 b, anti-IL-6R antibodies dampened MCL-1 expression induced by the toxin-producing Newman strain; however, the antibodies had no significant effect on cells infected with the Δ hla mutant. Together, these results demonstrate that α-toxininduced MCL-1 expression is mediated by IL-6.
The Role of Extracellular TLR-Dependent Signaling in S. aureus-Dependent Mcl-1 Upregulation
The activation of signaling pathways in response to bacterial infection is mediated by a broad range of pattern-recognition receptors. Amongst such extracellular receptors, S. aureus interacts mostly with TLR2. As such, the participation of TLR2 and TLR4 in the induction of Mcl-1 expression by S. aureus was assessed using anti-TLR2 and anti-TLR4 neutralizing antibodies. Pretreat- ment of hMDMs with anti-TLR2 antibodies only partially inhibited (31.5 ± 10.5% inhibition) the Mcl-1 expression induced by S. aureus whereas anti-TLR4 antibodies had no effect ( fig. 5 a) . Similar results were obtained for IL-6 secretion, which was marginally inhibited only by TLR2-neutralizing antibodies ( fig. 5 b) . The partial effect of blocking TLR2-mediated signaling pathways on both IL-6 and Mcl-1 expression suggests the involvement of alternative receptors in S. aureus recognition.
Intracellular Recognition of S. aureus Plays a Role in α-Toxin-Dependent Mcl-1 Expression
α-Toxin facilitates escape of the pathogen to the cytoplasm, thus ensuring the access of bacterial cell wall components to the cytoplasmic milieu [7] . Therefore, the involvement of an alternative intracellular recognition receptor would explain the lack of significant inhibition of Mcl-1 and IL-6 expression by blocking extracellular TLRdependent signaling pathways ( fig. 5 a, b) . Since activation of the NFκB transcription factor is a crucial step in the regulation of cell survival, which can regulate both Mcl-1 and IL-6 expression, we therefore determined the effect on NFκB activity of inhibiting bacterial engulfment. As expected, bacterial internalization was significantly inhibited by treating cells with cytochalasin D (5 μ M; fig. 6 a) . Interestingly, NFκB activity induced by toxin-producing S. aureus was also significantly inhibited by cytochalasin D, yet there was no effect on NFκB activation induced by the Δ hla mutant ( fig. 6 b) . This observation was confirmed by the MCL-1 expression profile ( fig. 6 c) and secretion of TNF-α and IL-6 cytokines, which are regulated by NFκB ( fig. 6 d, e) . These results confirm the role of α-toxin in amplifying antiapoptotic signaling pathways by S. aureus through exposure of antigens to intracellular receptors other than extracellular TLR.
α-Toxin Contributes Significantly to the Inhibition of Macrophage Apoptosis
Once we had demonstrated that α-toxin potentiated the Mcl-1 expression induced by S. aureus , we set out to investigate the role of α-toxin in cytoprotection mediated by a hMDMs were incubated for 6 and 24 h with either the WT Newman strain or Δ hla mutant at a MOI of 50, in the presence or absence of α-toxin (rHla, 30 ng/ml), or conditioned media (0.3% v/v). IL-6 levels in supernatants were determined by ELISA. Data represent the mean ± SD of 3 independent experiments; * p < 0.05; * * p < 0.01. b hMDMs were preincubated with anti-IL-6R antibodies (1 μg/ml) for 30 min, and then infected with the indicated S. aureus strains (WT or Δhla) at a MOI of 1: 50 or stimulated with IL-6 (200 ng/ml). At 7 h after infection, RNA was extracted and relative MCL-1 expression was measured using qRT-PCR. Mean values calculated from at least 3 independent experiments using hMDMs derived from different donors are shown. Bars represent mean relative expression ± SD. * p < 0.05; n.s. = not significant. S. aureus in more detail. Accordingly, murine macrophages (RAW 264.7 cells) were separately infected with either the Newman parent or its Δ hla mutant, followed by induction of apoptosis with staurosporin. As described previously [8] , bacterial PGN induces intracellular signaling and subsequent cytokine secretion, so S. aureus PGN was used as an additional control. At 2 h after infection (or treatment with 2 μg/ml of PGN), apoptosis was induced with staurosporin. All tested conditions resulted in a 2-to 6-fold inhibition of caspase-3 activity induced by staurosporin ( fig. 7 ) . Importantly, the Newman strain induced significantly stronger inhibition than the Δ hla mutant, while PGN yielded the weakest effect. Additional treatment of RAW 264.7 cells with conditioned media collected from the WT (α-toxin-positive) strain resulted in enhanced cytoprotection in cells infected with either of the two bacterial strains as well as those treated with PGN ( fig. 7 ) . Together, these results demonstrate that complementation of bacterial infection with α-toxin leads to a stronger inhibition of apoptosis in staurosporin-treated macrophages. These results are consistent with our Mcl-1 expression data ( fig. 3 b) and confirm the protective role of Mcl-1, mediated by α-toxin. 
Discussion
Staphylococcus aureus invades macrophages and promotes cytoprotection of infected cells, thus creating a safe niche for silent persistence. This process occurs through the upregulation of crucial antiapoptotic genes and, particularly, MCL-1 . The increase of Mcl-1 expression, which occurs shortly after infection and is sustained at high levels long after the engulfment of live S. aureus , is in stark contrast to the effects induced by Escherichia coli , heat-killed staphylococci or latex beads. This strongly argues that Mcl-1 expression is specifically induced and maintained by factors released by viable intracellular staphylococci [13] . Furthermore, only α-toxin-positive S. aureus strains are able to survive phagocytosis by macrophages beyond 24 h after infection [7] , suggesting that this toxin may function as an effector molecule. Consistent with this idea, strains that possess high α-toxin levels induce significantly higher levels of Mcl-1, and consequently exert stronger cytoprotective effects. Conversely, our data reveal that α-toxin does not act alone, but rather in conjunction with other bacterial antigens, e.g. PGN. Thus, the effects of α-toxin are indirect, and promote escape of bacteria from the phagosomes into the cytosol ( fig. 7 ) , akin to that recently reported for professional phagocytes [7] . This process of releasing S. aureus from the endosomes of epithelial cells is also complemented by other pathogen-derived toxins, such as δ-toxin and β-toxin [6, 15] . This facilitates the recognition of PAMPs (pathogen-associated molecular patterns) from S. aureus by intracellular receptors. This hypothesis is strongly supported by results showing that the inhibition of extracellular TLRs does not ablate Mcl-1 induction, which argues for additional and alternative intracellular PAMP sensing. Such a candidate molecule is NOD2, since its abundance is dramatically increased in infected macrophages (online suppl. table S1; qRT-PCR data from 6 independent blood donors revealed 3.6-to 11.3-fold increases above mock-infected cells), suggesting that NOD2 might be involved in sensing the presence of intracellular S. aureus . This would be in agreement with recent findings by Hruz et al. [8] , showing that NOD2-dependent recognition of S. aureus and muramyl dipeptide is facilitated by α-toxin; and is associated with the induction of cytokine release, including IL-6 and IL-8. In this context, the finding that IL-6 secretion by macrophages was enhanced by S. aureus in the presence of α-toxin lends further support to the idea that NOD2 is exploited by intracellular S. aureus . This leads to increased levels of Mcl-1, and subsequent cytoprotection through an as yet unknown intracellular receptor ( fig. 8 ) . Work is currently underway in our laboratory to specifically determine the identity of this protein.
Such a hypothesis is in agreement with the observation that the autocrine role of IL-6 has previously been shown to be essential for S. aureus -induced Mcl-1 expression, and for cytoprotection in infected macrophages ( fig. 8 ) [13] . As such, the fact that cytochalasin D had differing effects on NFκB activation and MCL-1 expression induced by α-toxin-producing and deficient strains, is perhaps the most compelling result in favor of a role for intracellular receptors in S. aureus -mediated signaling. This is supported by the observation that IL-6 regulation in infected macrophages is at least partly mediated by NFκB activation. As expected, blocking phagocytosis of the toxin-null mutant did not affect signaling via extracellular TLRs, and subsequent NFκB activation. Conversely, the same treatment significantly reduced NFκB activation by toxin-positive strains, presumably because it prevented pathogen recognition by intracellular PAMP receptors. These findings clearly indicate that extracel- Cytoprotection of S. aureus -infected macrophages is dependent on α-toxin. The enhancement of S. aureus (Newman WT and Δ hla mutant) and/or PGN-mediated caspase-3 inhibition by bacterial-conditioned media was measured using DEVD-AFC as a substrate. RAW 264.7 cells were infected with S. aureus (MOI 1: 5) or treated with PGN (2 μg/ml) for 2 h, with or without bacterial growth media (0.3% v/v) added, followed by stimulation for 6 h with STS. Bars represent mean ± SD of caspase-3 activity (RFU/ min) from 3 independent experiments. The caspase-3 activity of mock-infected cells treated with STS was set as 100%. * p < 0.05; * * p < 0.01. lular TLRs play a major role in signal transduction pathways engaged by α-toxin-deficient staphylococcal strains, since intracellular receptors would be inaccessible to them.
Work by others has shown that α-toxin alone is sufficient to induce cell death in host cells [16] , with higher concentrations predominantly producing necrosis, and low doses resulting in apoptosis [17] . Notably, in our studies, neither culture supernatants nor purified α-toxin at any of the concentrations tested affected hMDM viability (online suppl. fig. S3 ). These results mirror the cellular response to live S. aureus . While in some cells, S. aureus induces rapid cell death [18, 19] , in macrophages, intracellular bacteria ensure protection of the infected cell against death [12] . Thus, we present a novel mechanism for the cellular response to S. aureus , facilitated by α-toxin located in intracellular niches that is specific to macrophages. This model is compatible with reports that α-toxin can facilitate membrane repair, not only through activation of the central regulators of membrane biogenesis (sterol regulatory element-binding proteins), but also by modulating p38 and EGF signaling [20] [21] [22] . Furthermore, the discovery of ADAM10 as a high-affinity α-toxin receptor confirms this novel role of α-toxin as a cell signaling modulator [23] . Indeed, the extracellular activity of α-toxin was also noted in our study, since the response of cytochalasin D-treated macrophages to WT and α-toxin-deficient strains, as monitored by NFκB activity and IL-6 expression, was dramatically different ( fig. 6 b, e) .
Our findings present a new face for α-toxin as a potent virulence factor. When expressed by S. aureus inside macrophages, the toxin facilitates the escape of bacteria into the cytoplasm [7] , modifies the host immune response and promotes the cytoprotection of infected macrophages ( fig. 8 ). Consequently, this enables these longlived, mobile immune cells to migrate away from the primary site of colonization, and facilitate dissemination of the pathogen. Additional in vivo studies are necessary to confirm whether this manipulation of macrophage viability contributes primarily to pathogen dissemination or is, conversely, actually beneficial to the host. (2) . Simultaneously, phagocytosed bacteria (3) escape from phagosomes through α-toxin-mediated lysis of the membrane (4). The cytoplasmic bacteria then interact with intracellular/cytoplasmatic receptors (5), triggering signaling pathways that lead to NFκB activation (6) . Activated NFκB either directly (7), or indirectly, via IL-6-dependent autocrine signaling (8), stimulates Mcl-1 expression, which results in cytoprotection of the infected cells.
